DEBITO Cambiamento Data
AbbVie USD 70.82B 2.04B 2026-06
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
ALKERMES USD 1.57B 10.58M 2026-09
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amgen USD 57.3B 19M 2026-06
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Cytokinetics USD 1.27B 18.17M 2026-06
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Exelixis USD 162.2M 3.73M 2026-09
Gilead Sciences USD 26.25B 4.07B 2026-06
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Pfizer USD 62.67B 523M 2026-09
Prothena USD 6.99M 663K 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Repligen USD 555.6M 135.35M 2026-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Teva Pharmaceutical Industries USD 16.98B 110M 2026-09
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09